£9.0M
The funding round was led by Eos Advisory and includes participation from the Scottish National Investment Bank.
CO
Cumulus Oncology
Cumulus Oncology builds spin-out companies to accelerate the development of new cancer treatments.
£9.0MTotal raised
Cumulus Oncology operates Europe's first oncology biotech creation business model, designing spin-out companies to develop novel cancer treatments. The firm employs specialised portfolio strategies and advanced decision-making platforms to de-risk early-stage therapeutics.
Categories
Founders
CW
Clare Wareing
Chief Executive Officer